• Welcome to Genegraft website

    GENEGRAFT is a ‘bench to bedside’ project aims to find a durable and efficient treatment for Recessive Dystrophic Epidermolysis Bullosa (RDEB) one of the most severe orphan diseases of the skin.

    The GENEGRAFT project is a collaborative project funded by the European Union as part of the 7th framework programme. GENEGRAFT - contract N° HEALTH-F2-2011-261392 - started on March 1st 2011 and will last 5 years.

  • News

    • Debra International congress 2014: Participation of GENGRAFT partners Read more
    • GENEGRAFT-EBGen Study: Study of immune tolerance and capacity for wound healing of patients with Recessive Dystrophic Epidermolysis Bullosa (RDEB) Read more
    • EUFETS Successully released of the clinical viral batch Read more



  •  RE(ACT) Congress: International congress on research of Rare and Orphan diseases March 9-12, 2016 Read more...

    • ECRD 2016 : The European Conference on Rare Diseases & Orphan Products May 26-28, 2016, Edingburgh Read more...

    Read more event